Wei Xia

2.2k total citations
44 papers, 1.6k citations indexed

About

Wei Xia is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wei Xia has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wei Xia's work include Ferroptosis and cancer prognosis (3 papers), Transplantation: Methods and Outcomes (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Wei Xia is often cited by papers focused on Ferroptosis and cancer prognosis (3 papers), Transplantation: Methods and Outcomes (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Wei Xia collaborates with scholars based in China, United States and Hong Kong. Wei Xia's co-authors include Philip S. Low, Ji‐Xin Cheng, Eric L. Matteson, Hong Zhang, Khalid Rahman, Cheng Peng, Wei Yue, Yanxi Zhou, Xiao Qi Wang and Albert Chan and has published in prestigious journals such as Blood, ACS Applied Materials & Interfaces and Journal of Medicinal Chemistry.

In The Last Decade

Wei Xia

40 papers receiving 1.6k citations

Peers

Countries citing papers authored by Wei Xia

Since Specialization

Citations

This map shows the geographic impact of Wei Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Xia more than expected).

Fields of papers citing papers by Wei Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Xia. The network helps show where Wei Xia may publish in the future.

Co-authorship network of co-authors of Wei Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Xia. A scholar is included among the top collaborators of Wei Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Xia. Wei Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mild Photothermal Therapy Combined with Capsaicin for Tumor Immunotherapy and Analgesia by Inhibiting TRPV1 Channels 2025 ·ACS Applied Materials & Interfaces ·Xin Wang, (unknown), (unknown), Ranran Wang, Zhigang Ji, Ruoxuan Wang, (unknown), (unknown), (unknown), Wei Xia, (unknown)	0
2	Safety and immunogenicity of COVID-19 vaccine ZF2001 in Chinese aged 60 years and older 2024 ·Lidong Gao, (unknown), Peng He, Shilong Yang, (unknown), Fangjun Li, Wei Xia, (unknown), Xilu Wang, (unknown), Ruyue Wang, (unknown), Lianpan Dai, George F. Gao, Zhongyu Hu, (unknown), (unknown), Yan Li	1
3	Small-Molecule Inhibitors of TIPE3 Protein Identified through Deep Learning Suppress Cancer Cell Growth In Vitro 2024 ·Cells ·(unknown), Zhen Lu, (unknown), Wei Xia, Yi Pan, Houjun Xia, Youhai H. Chen, Haiping Zhang	1
4	Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial 2024 ·BMC Infectious Diseases ·Tao Huang, Qianqian Hu, Zhou Xiang, Huaiyu Yang, Wei Xia, (unknown), (unknown), (unknown), (unknown), (unknown), Lidong Gao, Jiufeng Sun, (unknown)	1
5	Metabolomic analysis identifies the regulation of lipid metabolism pathway as potential mechanisms of Jiangzhi decoction against non-alcoholic fatty liver disease 2023 ·Journal of Pharmacy and Pharmacology ·Lei Wang, Yin Zhi, Ying Ye, Miao Zhang, (unknown), Wei Xia, Yanan Song	4
6	Protective effects and regulatory mechanisms of Shen-shuai-yi recipe on renal fibrosis in unilateral ureteral obstruction-induced mice 2023 ·Heliyon ·(unknown), (unknown), (unknown), (unknown), Wei Xia, (unknown), (unknown), Yu Cao, Guang‐Bo Ge, Wei Liu, Xiaoli He, Jing Hu	2
7	Analysis of BRCA Germline Mutations in Chinese Prostate Cancer Patients 2022 ·Frontiers in Oncology ·Wei Chen, Wei Xia, Song Xue, Hang Huang, Qi Lin, Yi Liu, Tongtong Liu, Yiqun Zhang, (unknown), Jianfei Wang, Yining Yang, Baijun Dong, Zhixian Yu	4
8	Effect of the solution-focused brief therapy on cancer-related fatigue in breast cancer patients under adjuvant chemotherapy: a randomized trial 2020 ·Translational Cancer Research ·Weimin Liu, (unknown), (unknown), Fang Liu, Wei Xia, (unknown), Lihui Liu	6
9	Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma 2018 ·Theranostics ·(unknown), Xiao Qi Wang, Ksh Chok, Kwan Man, Simon H. Y. Tsang, Albert Chan, Ka Wing, Wei Xia, Tan To Cheung	160
10	GINS2 promotes cell proliferation and inhibits cell apoptosis in thyroid cancer by regulating CITED2 and LOXL2 2018 ·Cancer Gene Therapy ·Ying Ye, Yanan Song, Saifei He, Juhua Zhuang, Guoyu Wang, Wei Xia	31
11	Anticancer effects of echinacoside in hepatocellular carcinoma mouse model and HepG2 cells 2018 ·Journal of Cellular Physiology ·Ying Ye, Yanan Song, Juhua Zhuang, Guoyu Wang, Jing Ni, Wei Xia	45
12	Gene expression profiling of brain metastatic cell from triple negative breast cancer: Understanding the molecular events 2017 ·Gene ·Li Zhou, (unknown), Dingsheng Liu, (unknown), Dandan Gao, Wei Xia	9
13	Differential response of macrophages to core–shell Fe3O4@Au nanoparticles and nanostars 2012 ·Nanoscale ·Wei Xia, Hyon-Min Song, Qingshan Wei, Alexander Wei	20
14	Imaging Sites of Infection Using a ^99mTc-Labeled Folate Conjugate Targeted to Folate Receptor Positive Macrophages 2012 ·Molecular Pharmaceutics ·Walter A. Henne, (unknown), (unknown), Wei Xia, Bindu Varghese, Philip S. Low	21
15	Folate-Targeted Therapies for Cancer 2010 ·Journal of Medicinal Chemistry ·Wei Xia, Philip S. Low	406
16	A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages 2008 ·Blood ·Wei Xia, (unknown), Eric L. Matteson, (unknown), Ji‐Xin Cheng, Philip S. Low	265
17	Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia 2005 ·Leukemia Research ·Wenlin Xu, Huiling Shen, (unknown), Baoan Chen, Wei Xia, Feng Gao, (unknown)	56
18	Development of cervical left to right shunt pulmonary hypertension model by using cuff technique in rats 2004 ·Wei Xia	1
19	Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy 2003 ·Vaccine ·Connie L. Finstad, Chang Yi Wang, Jacek Kowalski, (unknown), (unknown), (unknown), Wei Xia, Maarten C. Bosland, Krishna K. Murthy, Alan M. Walfield, Wayne C. Koff, Timothy J. Zamb	20
20	La escala de Jacob 1990 ·Dialnet (Universidad de la Rioja) ·(unknown), Wei Xia, Guodong Fang, (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact